Acasti Pharma Inc. (ACST)
3.37
0.13 (4.01%)
At close: Oct 25, 2024, 8:00 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 |
| Net Income | -12.85M | -42.43M | -9.82M | -19.68M | -25.51M | -38.62M | -16.65M | -4.66M | -1.32M | -10.44M | -6.73M | -6.54M | -2.43M | -1.51M |
| Depreciation & Amortization | 11.00K | 124.00K | n/a | 924.00K | 2.32M | 2.12M | 2.07M | 1.77M | 1.87M | 1.59M | 649.60K | 671.76K | 13.34K | 8.62K |
| Stock-Based Compensation | 913.00K | 1.81M | 1.34M | 1.17M | 1.95M | 779.66K | 719.37K | 227.74K | 1.24M | 3.09M | 1.87M | 1.33M | 108.14K | n/a |
| Other Working Capital | -1.36M | 181.41K | -2.77M | -6.00M | -3.79M | 6.68M | 3.20M | -167.28K | 547.36K | -973.84K | 1.71M | -481.07K | n/a | n/a |
| Other Non-Cash Items | 1.73M | 33.94M | -5.32M | 264.00K | 145.00K | 4.91M | 1.40M | -2.43M | -8.58M | 729.73K | -85.35K | -11.98K | -0.00 | 0.00 |
| Deferred Income Tax | -1.83M | -9.54M | -648.00K | 8.94M | 1.36M | 435.14K | -5.42K | 277.29K | 1.28K | -83.53K | 12.38K | -12.86K | n/a | n/a |
| Change in Working Capital | -1.28M | 181.00K | -2.79M | -5.95M | -3.21M | 6.06M | 2.77M | -30.97K | 1.04M | -1.01M | 1.79M | -1.08M | 401.48K | -402.31K |
| Operating Cash Flow | -12.33M | -15.91M | -17.23M | -14.32M | -22.94M | -24.32M | -9.69M | -4.85M | -5.75M | -6.12M | -2.49M | -5.65M | -1.90M | -1.90M |
| Capital Expenditures | -22.00K | -17.00K | n/a | -69.00K | -319.00K | -524.27K | -352.33K | -271.25K | -68.67K | -133.56K | -100.68K | n/a | -21.58K | -15.36K |
| Acquisitions | 111.00K | 5.03M | n/a | 9.88M | 2.24M | 1.23 | n/a | -67.58K | -40.98K | -111.09K | n/a | n/a | n/a | n/a |
| Purchase of Investments | -6.55M | -5.01M | -34.93M | -9.81M | -1.92M | -17.79M | -20.13K | -8.82M | -11.57M | -22.82M | n/a | -7.54M | -2.56M | n/a |
| Sales Maturities Of Investments | 6.57M | 18.18M | 31.41M | 21.00K | 10.38M | 8.94M | n/a | 15.08M | 17.70M | 5.39M | 1.95M | 4.53M | n/a | 1.92M |
| Other Investing Acitivies | 89.00K | -5.03M | -4.40K | -9.88M | -2.24M | 287.60K | 54.20K | 151.50K | 73.74K | 199.29K | 1.74K | 8.17K | 0.00 | n/a |
| Investing Cash Flow | 104.00K | 13.15M | -3.52M | -9.86M | 8.14M | -9.09M | -318.26K | 6.07M | 6.10M | -17.48M | 1.85M | -3.01M | -2.59M | 1.90M |
| Debt Repayment | n/a | n/a | n/a | n/a | -1.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -30.97K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 7.36M | 410.86K | n/a | 158.00K | 7.75M | 726.48K | 295.02K | -1.79K | 36.72K | 846.80K | 221.53K | 55.61K | n/a | n/a |
| Financial Cash Flow | 7.36M | 304.00K | n/a | 59.49M | 13.18M | 44.08M | 8.83M | -1.79K | 36.72K | 22.44M | 221.53K | 9.94M | 4.40M | 77.40K |
| Net Cash Flow | -4.87M | -2.46M | -20.60M | 36.70M | -2.63M | 10.71M | -1.20M | 1.27M | 507.58K | -468.32K | -384.12K | 1.27M | -92.68K | 80.18K |
| Free Cash Flow | -12.36M | -15.93M | -17.23M | -14.39M | -23.26M | -24.85M | -10.05M | -5.12M | -5.82M | -6.25M | -2.59M | -5.65M | -1.93M | -1.92M |